Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC.

Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, Sauter JL, Choi H, Tenet M, Abu-Akeel M, Plodkowski AJ, Perez-Johnston R, Yoo CH, Ko RB, Stehr H, Gojenola L, Wakelee HA, Padda SK, Neal JW, Chaft JE, Kris MG, Rudin CM, Merghoub T, Li BT, Alizadeh AA, Diehn M.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3418.2019. doi: 10.1158/1078-0432.CCR-19-3418. [Epub ahead of print]

PMID:
32046999
2.

Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade.

Osorio JC, Arbour KC, Le DT, Durham JN, Plodkowski AJ, Halpenny DF, Ginsberg MS, Sawan P, Crompton JG, Yu HA, Namakydoust A, Nabet BY, Chaft JE, Riely GJ, Rizvi H, Diaz LA Jr, Hellmann MD.

J Clin Oncol. 2019 Dec 20;37(36):3546-3555. doi: 10.1200/JCO.19.00709. Epub 2019 Nov 1.

PMID:
31675272
3.

Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.

Li I, Nabet BY.

Mol Cancer. 2019 Mar 1;18(1):32. doi: 10.1186/s12943-019-0975-5. Review.

4.

Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.

Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, Liao JC, Alizadeh AA, Diehn M.

Cancer Discov. 2019 Apr;9(4):500-509. doi: 10.1158/2159-8290.CD-18-0825. Epub 2018 Dec 21.

5.

Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.

Nabet BY, Qiu Y, Shabason JE, Wu TJ, Yoon T, Kim BC, Benci JL, DeMichele AM, Tchou J, Marcotrigiano J, Minn AJ.

Cell. 2017 Jul 13;170(2):352-366.e13. doi: 10.1016/j.cell.2017.06.031.

6.

Linking primary and metastatic tumour re-initiation.

Nabet BY, Minn AJ.

Nat Cell Biol. 2015 May;17(5):542-3. doi: 10.1038/ncb3173.

PMID:
25925584
7.

Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.

Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, Ter Brugge PJ, Jonkers J, Slingerland J, Minn AJ.

Cell. 2014 Oct 23;159(3):499-513. doi: 10.1016/j.cell.2014.09.051.

8.

Basal and stress-induced Hsp70 are modulated by ataxin-3.

Reina CP, Nabet BY, Young PD, Pittman RN.

Cell Stress Chaperones. 2012 Nov;17(6):729-42. doi: 10.1007/s12192-012-0346-2. Epub 2012 Jul 10.

9.

Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.

Gilad O, Nabet BY, Ragland RL, Schoppy DW, Smith KD, Durham AC, Brown EJ.

Cancer Res. 2010 Dec 1;70(23):9693-702. doi: 10.1158/0008-5472.CAN-10-2286. Epub 2010 Nov 23.

Supplemental Content

Loading ...
Support Center